| 发明名称 |
RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (A) [LP(A)] BY INHIBITING APOLIPOPROTEIN (A) [APO(A)] |
| 摘要 |
Enzymatic RNA molecules which cleave apo(a) mRNA. Use of these catalytic RNA molecules for the treatment of conditions related to lipoprotein A levels, such as atherosclerosis, myocardial infarction, strokes; testenosis and heart diseases.
|
| 申请公布号 |
CA2199727(A1) |
申请公布日期 |
1996.03.28 |
| 申请号 |
CA19952199727 |
申请日期 |
1995.09.21 |
| 申请人 |
RIBOZYME PHARMACEUTICALS, INC. |
发明人 |
STINCHCOMB, DAN T.;MCSWIGGEN, JAMES;NEWTON, ROGER S.;RAMHARACK, RANDY |
| 分类号 |
C12N15/09;A61K31/70;A61K38/00;A61K48/00;A61P9/00;A61P9/10;C12N5/10;C12N9/00;C12N15/113;(IPC1-7):C12N15/11;C07H21/02;C12N9/22 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
